For the last 30 years, the production of affinity reagents and particularly antibodies for research and therapeutic applications has been dominated by hybridoma and polyclonal technologies ...

Vincerx has an experienced management team to advance the company’s therapeutic platform of ... from rudimentary constructs of polyclonal antibodies noncovalently linked to a cytotoxin, to ...

Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality antibodies that offer exceptional specificity and sensitivity.

Monoclonal antibodies have commercial value as research reagents, in diagnostic assays, and in therapeutic applications. Polyclonal antibodies also have potential value when large quantities of sera ...

View Full Profile. Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are ...